Myasthenia gravis

Anthony Kincaid

doi:10.1016/B978-008055232-3.60686-5

Myasthenia gravis

Anthony Kincaid

Department of Pharmacy Sciences

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Myasthenia gravis is a disorder of neuromuscular transmission that results in skeletal muscle weakness. The affected individual produces antibodies that are directed against their own nicotinic acetylcholine receptors. The circulating antibodies interfere with binding of acetylcholine to the ....

Original language	English
Title of host publication	xPharm: The Comprehensive Pharmacology Reference
Publisher	Elsevier Inc.
Pages	1-5
Number of pages	5
ISBN (Print)	9780080552323
DOIs	https://doi.org/10.1016/B978-008055232-3.60686-5
Publication status	Published - 2011

Fingerprint

All Science Journal Classification (ASJC) codes

Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Kincaid, A. (2011). Myasthenia gravis. In xPharm: The Comprehensive Pharmacology Reference (pp. 1-5). Elsevier Inc.. https://doi.org/10.1016/B978-008055232-3.60686-5

@inbook{7bb1a71978474f11b388b71994fb87f6,

title = "Myasthenia gravis",

abstract = "Myasthenia gravis is a disorder of neuromuscular transmission that results in skeletal muscle weakness. The affected individual produces antibodies that are directed against their own nicotinic acetylcholine receptors. The circulating antibodies interfere with binding of acetylcholine to the ....",

author = "Anthony Kincaid",

year = "2011",

doi = "10.1016/B978-008055232-3.60686-5",

language = "English",

isbn = "9780080552323",

pages = "1--5",

booktitle = "xPharm: The Comprehensive Pharmacology Reference",

publisher = "Elsevier Inc.",

address = "United States",

}

TY - CHAP

T1 - Myasthenia gravis

AU - Kincaid, Anthony

PY - 2011

Y1 - 2011

N2 - Myasthenia gravis is a disorder of neuromuscular transmission that results in skeletal muscle weakness. The affected individual produces antibodies that are directed against their own nicotinic acetylcholine receptors. The circulating antibodies interfere with binding of acetylcholine to the ....

AB - Myasthenia gravis is a disorder of neuromuscular transmission that results in skeletal muscle weakness. The affected individual produces antibodies that are directed against their own nicotinic acetylcholine receptors. The circulating antibodies interfere with binding of acetylcholine to the ....

UR - http://www.scopus.com/inward/record.url?scp=84884059540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884059540&partnerID=8YFLogxK

U2 - 10.1016/B978-008055232-3.60686-5

DO - 10.1016/B978-008055232-3.60686-5

M3 - Chapter

AN - SCOPUS:84884059540

SN - 9780080552323

SP - 1

EP - 5

BT - xPharm: The Comprehensive Pharmacology Reference

PB - Elsevier Inc.

ER -

Access to Document

10.1016/B978-008055232-3.60686-5